Compare Mutual Funds
Pros | Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | 4/8 | 2/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 10 Years 4 Months | 7 Years 9 Months | ||
Fund AUM | ₹1301 Cr | ₹6801 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.69% | 1.02% | ||
Exit Load | 0.25% | 1% | ||
Benchmark Index | Nifty Pharma TR INR | BSE Healthcare TR INR |
No of Holdings | 36 | 43 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 2 | 2 | ||
Top 3 Sectors |
|
| ||
Equity % | 97.59% | 97.98% | ||
Debt % | - | - | ||
P/E | 41.15 | 32.15 | ||
P/B | 6.83 | 3.94 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -2.61% | -1.31% | ||
3-Month Return | -2.59% | -4.79% | ||
6-Month Return | -5.64% | -7.86% | ||
1-Year Return | 5.33% | 6.31% | ||
3-Year Return | 25.03% | 28.52% | ||
5-Year Return | 17.51% | 18.82% |
Sharpe | 1.13 | 1.3 | ||
Alpha | 1 | 2.27 | ||
Beta | 0.95 | 0.94 | ||
Standard Deviation | 16.16 | 15.86 | ||
Information Ratio | 0.04 | 0.44 |
Description | Tata India Pharma & Healthcare Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Rajat Srivastava | Sharmila D’mello, Dharmesh Kakkad |

